Phenomenex Inaugurates China R&D Center to Advance Danaher's "Launching China" Strategy

Phenomenex Inaugurates China R&D Center to Advance Danaher’s “Launching China” Strategy

California-based Phenomenex, a leading manufacturer of chromatography consumables, announced the inauguration of its R&D center in Tianjin, China. This strategic move underscores the company’s commitment to advancing Danaher Corporation’s (NYSE: DHR) “Launching China” strategy.

Strategic Integration
As a member of Danaher Corporation’s Life Science Platform, Phenomenex aims to leverage the quality control advantages of China’s supply chain and its Tianjin production base. The new R&D center will serve as a hub for innovation and development, focusing on enhancing chromatography technologies and solutions tailored to the growing needs of the Chinese market.-Fineline Info & Tech

Leave a Reply

Your email address will not be published. Required fields are marked *

Insight, China's Pharmaceutical Industry